Zen Technologies Q2 FY27 slides: revenue doubles, margins top 38%

Zen Technologies reported record Q2FY27 revenue of ₹345.13 crore, up 98.8% year over year, operational EBITDA up 103.9% to ₹131.99 crore and a 38.2% operational margin; PAT rose 50.7% to ₹89.54 crore. Q2 orders of ₹481.81 crore lifted the September 30 order book to ₹1,375.70 crore, while FY2027 revenue guidance remained ₹1,200–1,300 crore. Shares rose 8.22% to $1,719 after the results, although the working-capital cycle widened to 379 days from 255 days at Q1 end, and management said margins should normalize toward 35%.

Analysis

The key issue is conversion, not demand: the order book is not equivalent to near-term revenue, particularly with AMC content and procurement timing embedded in it. Against FY27 guidance, H2 must deliver roughly ₹713–813 crore—materially above H1—so the thesis now depends on a sharp step-up in execution. A 379-day working-capital cycle raises the possibility that reported growth consumes cash before customer collections; the cash balance cushions this, but does not eliminate the risk if receivables and inventory keep rising.

Near term, the post-results rally may have pulled forward credit for the domestic procurement tailwind. The more useful 1–3 month checks are simulator order conversion, receivables/inventory, and whether management gives evidence that H2 delivery is on schedule. The 38.2% operational margin should not be extrapolated: management itself expects normalization toward 35%, while the exceptional quarter may reflect product/order mix and execution leverage.

Over 6–18 months, in-house counter-drone capability and adjacent subsidiaries could broaden addressable programs, but export contribution remains small and counter-UAS timing is uncertain. HyperStrike is not a near-term earnings driver. Procurement deferrals, customer payment delays, or a reversal in domestic preference are the principal downside catalysts. The stated dollar-denominated consensus miss is inconsistent with the rupee revenue figures and should be verified before using it; likewise, independently confirm order awards and conversion schedules. A thesis break would be H2 guidance slippage, continued working-capital deterioration without collection improvement, or operational margins falling materially below the guided mid-30% range.

Key Decisions for Investors

• Avoid chasing the immediate gap higher; hold existing exposure only if sized for procurement and working-capital volatility. Consider trimming into strength rather than underwriting HyperStrike or counter-UAS orders as near-term earnings.
• Set an alert for the next update on receivables, inventory, and operating cash flow. Treat a rising working-capital cycle without improving collections as a negative signal even if EBITDA remains strong.
• Reassess after evidence that the expected simulator orders are awarded and scheduled for delivery. If H2 execution visibility weakens or FY27 guidance is cut, reduce exposure; if conversion and cash collection improve while margins remain near guidance, the growth thesis is better validated.